PVCT - Provectus Biopharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development8,543.07411,379.6895,809.047
Selling General and Administrative15,968.94913,274.07211,002.326
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-24,512.023-24,653.761-16,811.373
Income from Continuing Operations
Total Other Income/Expenses Net84.753151.4216,568.383
Earnings Before Interest and Taxes-24,427.27-24,502.34-10,242.99
Interest Expense---
Income Before Tax-24,427.27-24,502.34-10,242.99
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-24,427.27-24,502.34-10,242.99
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,427.27-24,502.34-10,242.99
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-28,859.513-24,502.34-10,242.99